Developer docs
API playgroundTry for free, no card

Search company profiles

Cardiatex

Full company profile

uuid02m2mny

Namestring
Cardiatex
Legal namestring
CardiaTex
Websiteurl
cardiatex.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

CardiaTex is a privately held biomedical technology startup headquartered at 1511 Texas Ave South in College Station, Texas, with 1–10 employees and origins in research conducted at Texas A&M University. The company develops a wearable cuffless blood pressure monitoring system that combines high-precision pressure transducers with AI-driven signal processing to deliver continuous, real-time arterial pressure measurements without the discomfort and intermittent nature of traditional cuff-based devices.

The core product is a single wearable sensor platform positioned to serve three end-user groups: individual patients for personal cardiovascular monitoring, physicians and healthcare providers for clinical decision support and remote patient monitoring, and academic/clinical researchers requiring non-invasive continuous data collection. Technical differentiation rests on a novel cuffless architecture, high-precision pressure sensing, and proprietary AI signal processing aimed at clinical-grade accuracy in a wearable form factor. No patents, regulatory clearances, third-party clinical validations, pricing details, or distribution channels are publicly disclosed.

The business model is not yet commercialized. Pricing is undisclosed, the website operates a contact-form-based inquiry model for collaboration, and no customers, revenue, funding rounds, management team, partnerships, or go-to-market channels are documented in available sources. The company appears to be in a pre-commercial development stage, with its principal disclosed asset being the underlying sensor-and-AI technology platform originating from university research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCollege Station, United States
HQ citystring
College Station
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable health devices, blood pressure monitoring, cardiovascular monitoring, biomedical sensors, cuffless monitoring
Industry3 codes
1Blood Pressure Monitoring (Cuff & Cuffless)
CodeHLAHACACPrimaryYes
2Blood Pressure Monitors (Smart Cuffs)
CodeCRACAQABPrimaryNo
3Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Cardiovascular Monitoring Devices
Social media profiles1 record
Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CardiaTex develops a wearable cuffless blood pressure monitoring system that integrates advanced pressure transducers with AI-driven signal processing to provide continuous, real-time cardiovascular insights. The product is designed for individual patients, physicians and healthcare providers, and cardiovascular researchers as a clinical-grade alternative to traditional cuff-based blood pressure monitors. The company is positioned as a biomedical technology startup originating from research conducted at Texas A&M University.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CardiaTex offers a single core product: a wearable cuffless blood pressure monitoring system. This unified device combines advanced pressure sensing technology with AI-powered analytics to provide continuous, real-time blood pressure tracking. The system is designed for patients, physicians, and researchers, enabling cardiovascular monitoring anytime, anywhere without the discomfort or limitations of traditional blood pressure cuffs.

Product and service1 record
1CardiaTex Wearable Cuffless Blood Pressure Monitor
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Biobeat
TypeDirect peer
Description

Israel-based company with FDA-cleared wearable chest-monitor and wrist-worn devices measuring continuous BP, heart rate, and other vitals. Direct competitor in cuffless continuous cardiovascular monitoring for clinical RPM.

2Caretaker Medical
TypeDirect peer
Description

Developer of FDA-cleared continuous non-invasive blood pressure (CNIBP) technology for clinical and perioperative use. Closely comparable non-invasive continuous arterial-pressure category competing for the same physician and clinical-research user.

3Masimo
TypeBroad incumbent
Description

Patient-monitoring incumbent expanding into continuous non-invasive vitals including hemodynamic parameters. Hospital-channel player competing for clinical RPM and patient-monitoring share relevant to CardiaTex's physician segment.

4Withings
TypeEmerging player
Description

Consumer health device maker (BPM Core, ScanWatch) with FDA-cleared blood pressure monitor with embedded cuff and ECG. Comparable hybrid approach spanning consumer wellness and clinical-grade metrics, competing for the same patient segment.

5Apple
TypeBroad incumbent
Description

Apple Watch's FDA-cleared hypertension notification feature positions Apple as a major platform incumbent in wrist-worn cardiovascular monitoring. Competes for patient/consumer BP awareness even without CardiaTex's clinical-accuracy profile.

6Aktiia
TypeDirect peer
Description

Swiss medical-grade wearable company with a CE-marked cuffless continuous blood pressure monitor using optical sensors. Direct head-to-head competitor in cuffless BP for both consumer and clinical channels.

7Samsung
TypeBroad incumbent
Description

Galaxy Watch integrates cuff-calibrated blood pressure measurement approved in multiple markets. Competes in the consumer wrist-worn BP category with massive global distribution and brand.

8VitalConnect
TypeEmerging player
Description

Maker of the FDA-cleared VitalPatch biosensor for continuous remote cardiac monitoring. Comparable wearable + AI + RPM architecture targeting the same clinical and RPM channel as CardiaTex.

9Omron Healthcare
TypeBroad incumbent
Description

Global incumbent in home and clinical BP monitoring with its own cuffless initiatives (HeartGuide smartwatch) and dominant retail channel position across OTC BP devices.

10Garmin
TypeBroad incumbent
Description

Wearable OEM expanding health-monitoring features (heart rate, sleep, ECG, BP via partners). Competes for the high-performance / active-user segment that CardiaTex explicitly targets.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cardiatex

Wearable Cardiovascular Monitoring Devicescardiatex.com

What Cardiatex does

CardiaTex is a privately held biomedical technology startup headquartered at 1511 Texas Ave South in College Station, Texas, with 1–10 employees and origins in research conducted at Texas A&M University. The company develops a wearable cuffless blood pressure monitoring system that combines high-precision pressure transducers with AI-driven signal processing to deliver continuous, real-time arterial pressure measurements without the discomfort and intermittent nature of traditional cuff-based devices.

The core product is a single wearable sensor platform positioned to serve three end-user groups: individual patients for personal cardiovascular monitoring, physicians and healthcare providers for clinical decision support and remote patient monitoring, and academic/clinical researchers requiring non-invasive continuous data collection. Technical differentiation rests on a novel cuffless architecture, high-precision pressure sensing, and proprietary AI signal processing aimed at clinical-grade accuracy in a wearable form factor. No patents, regulatory clearances, third-party clinical validations, pricing details, or distribution channels are publicly disclosed.

The business model is not yet commercialized. Pricing is undisclosed, the website operates a contact-form-based inquiry model for collaboration, and no customers, revenue, funding rounds, management team, partnerships, or go-to-market channels are documented in available sources. The company appears to be in a pre-commercial development stage, with its principal disclosed asset being the underlying sensor-and-AI technology platform originating from university research.

Cardiatex firmographics

Firmographics
Name
Cardiatex
Legal name
CardiaTex
Website
https://cardiatex.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Cardiatex industry classification

Industry
Product category
Wearable Cardiovascular Monitoring Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Blood Pressure Monitoring (Cuff & Cuffless) (HLAHACAC)
akta.pro secondary industries
Blood Pressure Monitors (Smart Cuffs) (CRACAQAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

  • Wearable health devices
  • Blood pressure monitoring
  • Cardiovascular monitoring
  • Biomedical sensors
  • Cuffless monitoring

Where Cardiatex is headquartered

Location

Headquarters

HQ city
College Station
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cardiatex business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Cardiatex product offering

Product offering

Core offering

CardiaTex develops a wearable cuffless blood pressure monitoring system that integrates advanced pressure transducers with AI-driven signal processing to provide continuous, real-time cardiovascular insights. The product is designed for individual patients, physicians and healthcare providers, and cardiovascular researchers as a clinical-grade alternative to traditional cuff-based blood pressure monitors. The company is positioned as a biomedical technology startup originating from research conducted at Texas A&M University.

Product overview

CardiaTex offers a single core product: a wearable cuffless blood pressure monitoring system. This unified device combines advanced pressure sensing technology with AI-powered analytics to provide continuous, real-time blood pressure tracking. The system is designed for patients, physicians, and researchers, enabling cardiovascular monitoring anytime, anywhere without the discomfort or limitations of traditional blood pressure cuffs.

Differentiator

Problem solved

Functional benefit

Products and services

  • CardiaTex Wearable Cuffless Blood Pressure Monitor

Companies that use Cardiatex

Customer profile

Segments3 records

Ideal customer profiles1 record

Cardiatex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Cardiatex partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Cardiatex competitors and assessment

Company assessment

Direct peers

  • Biobeat: Israel-based company with FDA-cleared wearable chest-monitor and wrist-worn devices measuring continuous BP, heart rate, and other vitals. Direct competitor in cuffless continuous cardiovascular monitoring for clinical RPM.
  • Caretaker Medical: Developer of FDA-cleared continuous non-invasive blood pressure (CNIBP) technology for clinical and perioperative use. Closely comparable non-invasive continuous arterial-pressure category competing for the same physician and clinical-research user.
  • Aktiia: Swiss medical-grade wearable company with a CE-marked cuffless continuous blood pressure monitor using optical sensors. Direct head-to-head competitor in cuffless BP for both consumer and clinical channels.

Broad incumbents

  • Masimo: Patient-monitoring incumbent expanding into continuous non-invasive vitals including hemodynamic parameters. Hospital-channel player competing for clinical RPM and patient-monitoring share relevant to CardiaTex's physician segment.
  • Apple: Apple Watch's FDA-cleared hypertension notification feature positions Apple as a major platform incumbent in wrist-worn cardiovascular monitoring. Competes for patient/consumer BP awareness even without CardiaTex's clinical-accuracy profile.
  • Samsung: Galaxy Watch integrates cuff-calibrated blood pressure measurement approved in multiple markets. Competes in the consumer wrist-worn BP category with massive global distribution and brand.
  • Omron Healthcare: Global incumbent in home and clinical BP monitoring with its own cuffless initiatives (HeartGuide smartwatch) and dominant retail channel position across OTC BP devices.
  • Garmin: Wearable OEM expanding health-monitoring features (heart rate, sleep, ECG, BP via partners). Competes for the high-performance / active-user segment that CardiaTex explicitly targets.

Emerging players

  • Withings: Consumer health device maker (BPM Core, ScanWatch) with FDA-cleared blood pressure monitor with embedded cuff and ECG. Comparable hybrid approach spanning consumer wellness and clinical-grade metrics, competing for the same patient segment.
  • VitalConnect: Maker of the FDA-cleared VitalPatch biosensor for continuous remote cardiac monitoring. Comparable wearable + AI + RPM architecture targeting the same clinical and RPM channel as CardiaTex.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Cardiatex social profiles

Digital presence

Cardiatex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cardiatex leadership team

Management profile

Number of profiles

Cardiatex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cardiatex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiatex

What does Cardiatex do?

CardiaTex develops a wearable cuffless blood pressure monitoring system that integrates advanced pressure transducers with AI-driven signal processing to provide continuous, real-time cardiovascular insights. The product is designed for individual patients, physicians and healthcare providers, and cardiovascular researchers as a clinical-grade alternative to traditional cuff-based blood pressure monitors. The company is positioned as a biomedical technology startup originating from research conducted at Texas A&M University.

Is Cardiatex a public or private company?

Cardiatex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cardiatex founded?

Cardiatex was founded in 2025. It employs 1 to 10 people.

Where is Cardiatex based?

Cardiatex is headquartered in College Station, United States, in the North America region.

Who are Cardiatex's main competitors?

Direct peers on record are Biobeat, Caretaker Medical and Aktiia. Broad incumbents are Masimo, Apple, Samsung, Omron Healthcare and Garmin. Emerging players are Withings and VitalConnect.

Does Cardiatex have an API?

No public API is recorded for Cardiatex.

What industry is Cardiatex in?

Cardiatex's product category is Wearable Cardiovascular Monitoring Devices. Its primary akta.pro industry code is HLAHACAC, Blood Pressure Monitoring (Cuff & Cuffless), with a secondary code of CRACAQAB, Blood Pressure Monitors (Smart Cuffs). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales